Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60.4M
-
Number of holders
-
260
-
Total 13F shares, excl. options
-
69.5M
-
Shares change
-
+2.62M
-
Total reported value, excl. options
-
$2.73B
-
Value change
-
+$98.7M
-
Put/Call ratio
-
0.54
-
Number of buys
-
135
-
Number of sells
-
-105
-
Price
-
$39.26
Significant Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q1 2025
297 filings reported holding TWST - Twist Bioscience Corp - Common stock, $0.00001 par value per share as of Q1 2025.
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) has 260 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.5M shares
.
Largest 10 shareholders include ARK Investment Management LLC (6.24M shares), VANGUARD GROUP INC (5.87M shares), Artisan Partners Limited Partnership (5.85M shares), BlackRock, Inc. (5.63M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (3.81M shares), Invesco Ltd. (3.38M shares), STATE STREET CORP (2.69M shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (2.44M shares), Sumitomo Mitsui Trust Group, Inc. (2.42M shares), and Nikko Asset Management Americas, Inc. (2.42M shares).
This table shows the top 260 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.